Recurrent goiter and amenorrhea-galactorrhea Syndrome in a patient with a thyrotrophin- and prolactin-producing pituitary adenoma by Horn, K. et al.
Seventh International 
Thyroid Conference 
Boston, Mass., June 9—13,1975 
PROGRAM 
ABSTRACTS OF PAPERS PRESENTED 
1975 
Excerpta Medica Princeton 
American Elsevier Publishing Co., Inc. New York 
© E X C E R P T A M E D I C A 1975 
A l l r i g h t s reserved. N o p a r t o f t h i s p u b l i c a t i o n may be r e p r o d u c e d , s t o r e d in a 
r e t r i e v a l S y s t e m o r t r a n s m i t t e d , i n any f o r m o r by any means, e l e c t r o n i c , m e c h a n i c a l , 
p h o t o c o p y i n g , r e c o r d i n g o r o t h e r w i s e , w i t h o u t p e r m i s s i o n i n w r i t i n g f r o m t h e 
p u b l i s h e r . 
International Congress Series No. 361 
I S B N Excerpta Medica 90 219 1219 8 
ISBN American Elsevier 0 444 15179 6 
Library of Congress Catalog Card Number 75-13862 
305 Keizersgracht 
Amsterdam 
P.O. Box 1126 
Excerpta Medica 
Nassau Building 
228 Alexander Street 
Princeton, N . J . 08540 
P u b l i s h e r : Excerpta Medica 
Sole D i s t r i b u t o r s f o r t h e USA a n d C a n a d a : 
American Elsevier Publishing Company, Inc. 
52 Vanderbilt Avenue 
New York , N . Y . 10017 
Printed in U S A 
SEVENTH THYROID CONFERENCE, BOSTON, 1975 
Officers 
P r e s i d e n t 
John B. Stanbury, Mass., U . S . A . 
G e n e r a l S e c r e t a r y 
Lewis E . Braverman, Boston, Mass., U . S . A 
T r e a s u r e r 
Joseph Benotti, Weston, Mass., U . S . A . 
V i c e P r e s i d e n t s 
Jack Gross, Israel 
Reginald Hall , United Kingdom 
Basil S. Hetzel, Australia 
Pavel Langer, Czechoslovakia 
Serge Lissitzky, France 
Farahe Maloof, U . S . A . 
Hector Perinetti, Argentina 
Gaetano Salvatore, Italy 
Kazuo Shizume, Japan 
D i s t i n g i i i s h e d T h y r o i d Seientists 
Edwin B. Astwood, Bermuda 
Paul Bastenie, Belgium 
H . D. Purves, New Zealand 
Andries Querido, The Netherlands 
J. Edward Ral l , U . S . A . 
Sidney C. Werner, U . S . A . 
P u b l i c a t i o n s C h a i r m a n 
Jacob Robbins, U . S . A . 
L o c a l A r r a n g e m e n t s C h a i r m a n 
Earle M . Chapman, U . S . A . 
A r n e r i c a n T h y r o i d A s s o c i a t i o n 
Secretary - Alvin B. Hayles, U . S . A . 
E u r o p e a n T h y r o i d A s s o c i a t i o n 
Secretary - Mario Andreoli , Italy 
S c i e n t i f i c P r o g r a m C o m m i t t e e 
Sidney H . Ingbar, U . S . A . 
W. Donald Alexander, United Kingdom 
Leslie J . DeGroot, U . S . A . 
Geraldo A . deMedeiros-Neto, Brazil 
Ragnar Ekholm, Sweden 
Andre M . Ermans, Belgium 
A. Gordon, Israel 
Bror-Axel Lamberg, Finland 
S. M . Milcu , Romania 
Shigenobu Nagataki, Japan 
Jacques Nunez, France 
Aldo Pinchera, Italy 
Hugo Studer, Switzerland 
Alvin Taurog, U . S . A . 




SESSION 1: Feedback control of thyroid function (A b s t r a c t s 1-6) 1 
SESSION 2: Thyroid stimulators (A b s t r a c t s 7-12) 4 
SESSION 3: Diagnostic methods ( A b s t r a c t s 1 3 - 1 8 ) 1 
SESSION 4: T R H and T S H ( A b s t r a c t s 1 9 - 2 5 ) 11 
SESSION 5: Iodine deficiency ( A b s t r a c t s 2 6 - 3 2 ) 15 
SESSION 6: Thyroid cell membranes (A b s t r a c t s 33 - 3 8 ) 19 
S E S S I O N 7: Anatomy and morphogenesis (A b s t r a c t s 3 9 - 4 4 ) 23 
SESSION 8: Autoimmunity and thyroid disease - I ( A b s t r a c t s 4 5 - 5 1 ) 26 
SESSION 9: Thyroid peroxidase and iodination mechanisms 
( A b s t r a c t s 5 2 - 5 8 ) 30 
SESSION 10: Cyclic nucleotides and Prostaglandins ( A b s t r a c t s 5 9 - 6 4 ) 34 
SESSION 11: Thyroid hormone effects ( A b s t r a c t s 6 5 - 7 0 ) 38 
SESSION 12: Special tf>chniques ( A b s t r a c t s 7 1 - 7 6 ) 41 
SESSION 13: Regulation of thyroid protein synthesis ( A b s t r a c t s 7 7 - 8 2 ) 45 
SESSION 14: Thyroid hormone receptors and metabolism 
( A b s t r a c t s 8 3 - 8 8 ) 48 
SESSION 15: Treatment of hyperthyroidism - I ( A b s t r a c t s 8 9 - 9 3 ) 52 
SESSION 16: Iodoproteins: biosynthesis and properties ( A b s t r a c t s 9 4 - 1 0 0 ) 55 
SESSION 17: Thyroid hormone secretion ( A b s t r a c t s 1 0 1 - 1 0 7 ) 59 
SESSION 18: Thyroid intermediary metabolism (A b s t r a c t s 1 0 8 - 1 1 2 ) 63 
S E S S I O N 19: Mechanisms of thyroid hormone action - I 
( A b s t r a c t s 1 1 3 - 1 1 8 ) 66 
SESSION 20: Defective thyroid hormone synthesis ( A b s t r a c t s 1 1 9 - 1 2 5 ) 70 
SESSION 21: Conversion of T4 to T3 - I ( A b s t r a c t s 1 2 6 - 1 3 1 ) 74 
SESSION 22: Treatment of hyperthyroidism - II ( A b s t r a c t s 1 3 2 - 1 3 6 ) 1 1 
SESSION 23: Autoimmunity and thyroid disease - II 
( A b s t r a c t s 1 3 7 - 1 4 2 ) 80 
SESSION 24: Mechanisms of thyroid hormone action - II 
( A b s t r a c t s 1 4 3 - 1 4 8 ) 83 
SESSION 25: T B G , T4 to T3 conversion - II ( A b s t r a c t s 1 4 9 - 1 5 4 ) 86 
SESSION 26: Thyroid tumors: biochemical aspects ( A b s t r a c t s 1 5 5 - 1 5 9 ) 90 
SESSION 27: Thyroid physiopathology ( A b s t r a c t s 1 6 0 - 1 6 4 ) 93 
SESSION 28: Symposium: Thyroid hormone structure-activity relation 
( A b s t r a c t s 1 6 5 - 1 6 9 ) 96 
SESSION 29: Thyroid tumors: clinical aspects ( A b s t r a c t s 1 7 0 - 1 7 4 ) 9 9 







( A b s t r a c t s 1 6 0 - 1 6 4 ) 
Chairman: A . B. H A Y L E S , Rochester, M i n n . , U.S.A. 
Co-chairman: B. A . L A M B E R G , H e l s i n k i , F i n l a n d 
160. Recurrent goiter and amenorrhea-galactorrhea Syndrome in a patient with a 
thyrotrophin- and prolactin-producing pituitary adenoma 
K . H O R N , R. F A H L B U S C H , U . H A C H M E I S T E R , C R . P I C K A R D T , 
K . v. W E R D E R and P. C. S C R I B A , München, F e d e r a l R e p u b l i c o f G e r m a n y 
A 22-year-old woman presented a history of hyperthyroidism, recurrent goiter with 
tracheal compression and concomitant amenorrhea and galactorrhea. These Symp-
toms originated from a T S H - and PRL -producing pituitary adenoma resulting in an 
enlarged sella turcica. Basal TSH-levels fluctuated between 11.9 and 2 9 . 4 / i U / m l 
and could not be suppressed by exogenous T3 and/or T4 medication, leading to 
thyrotoxic hormone levels (T3: 392 ng/100 ml ; T4 : 17.5 jug/100 ml). The P R L -
levels were 10 times above normal, between 154 and 328 ng/ml. Stimulation with 
T R H (200 jug i.v.) caused only an insignificant increase of TSH-and PRL-levels. In 
contrast to the Stimulation test, suppression of T S H - and PRL-secretion occurred 
with the same kinetics after oral administration of 500 mg L-dopa (from 26.2 to 
18.8 / i U / m l T S H and from 226 to 90 ng/ml P R L ) and after 5 mg 2-Br-a-ergocryp-
tine with a nadir after 3 hr (TSH: from 11.9 to 6 . 4 / i U / m l ; P R L : from 155 to 
37 ng/ml). The immediate decrease of T S H - and PRL-levels after transsphenoidal 
hypophysectomy combined with cryotherapy was again parallel and approached 
levels below normal. 
Electron microscopic examination of the adenoma revealed two types of cells 
with distinct secretory granules. One cell type could be identified as lactotrophic. 
The other cells, most likely producing T S H , had long cell bodies and secretory 
granules with a diameter of 9 0 - 2 0 0 nm, some of them bound to the cell membrane. 
Both cell types were found closely associated and spread all over the adenoma. 
These clinical and ultrastructural findings give for the first time strong evidence 
for an autonomous adenoma of the pituitary producing both T S H and P R L . 
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